Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Lorena Lopez-Gonzalez"'
Autor:
Lowell Hart, Augustina Ogbonnaya, Kristen Boykin, Kathryn Deyoung, Ray Bailey, Trevor Heritage, Lorena Lopez‐Gonzalez, Huan Huang, Lucio Gordan
Publikováno v:
Cancer Medicine, Vol 12, Iss 8, Pp 10020-10030 (2023)
Abstract Background Myelosuppression is a major dose‐limiting complication of chemotherapy for patients with extensive‐stage small cell lung cancer (ES‐SCLC). The objective was to describe the burden of myelosuppression, treatment patterns, and
Externí odkaz:
https://doaj.org/article/60e593f5c1924c05bcb67c31cdfa6cbd
Autor:
Jerome Goldschmidt, Alisha Monnette, Ping Shi, Divea Venkatasetty, Lorena Lopez-Gonzalez, Huan Huang
Publikováno v:
Future oncology (London, England).
Our objective was to describe the burden of myelosuppression, a side effect of chemotherapy that results from damage to blood-forming cells in the bone marrow, among patients with extensive-stage small cell lung cancer (ES-SCLC). We evaluated the pre
Autor:
Jerome Goldschmidt, Alisha Monnette, Ping Shi, Divea Venkatasetty, Lorena Lopez-Gonzalez, Huan Huang, Paul R Conkling
Publikováno v:
International Journal of Cancer Care and Delivery. 2
Autor:
Lowell Hart, Augustina Ogbonnaya, Kristen Boykin, Kathryn Deyoung, Ray Bailey, Trevor Heritage, Lorena Lopez-Gonzalez, Huan Huang, Lucio Gordan
Publikováno v:
International Journal of Cancer Care and Delivery. 2
Autor:
Janna Manjelievskaia, Cynthia D Morrow, Pisit Pitukcheewanont, Paul Kaplowitz, Lorena Lopez-Gonzalez, Alden Smith
Publikováno v:
Journal of the Endocrine Society
Pediatric GHD is a rare disorder of short stature that is currently treated with daily injections of GH. In addition to short stature, GHD is associated with other comorbidities such as impaired musculoskeletal development, cardiovascular disease, an
Autor:
George Shrady, Elizabeth Hoit Marchlewicz, Diane J Martinez, Yang Zhao, Steven R. Feldman, Jingchuan Zhang, Lorena Lopez-Gonzalez, Alan M. Mendelsohn
Publikováno v:
Dermatology online journal. 27(1)
Plaque psoriasis is a chronic disease requiring long-term therapy. However, long-term real-world treatment patterns and costs are not well characterized. This study examined treatment patterns and healthcare costs among patients newly initiating a bi
Autor:
Ervant J Maksabedian Hernandez, Bradley S. Stolshek, Lorena Lopez-Gonzalez, Joseph Tkacz, Kate Higgins, Alexis Ogdie
Publikováno v:
The American journal of managed care. 26(8)
Objectives Pharmacologic treatment for psoriatic arthritis (PsA) includes traditional oral small molecules (OSMs), tumor necrosis factor inhibitors (TNFis), and newer oral therapies such as a phosphodiesterase-4 (PDE4) inhibitor and a Janus kinase in
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 18:573-580
Infections, cytopenia, and gastrointestinal (GI) toxicity are adverse events of special interest (AESI) affecting most relapsed Philadelphia chromosome-negative (Ph-) B-cell acute lymphocytic leukemia (ALL) patients. This study quantified real-world
Autor:
Yang Zhao, Jingchuan Zhang, Alan M. Mendelsohn, George Shrady, Lorena Lopez-Gonzalez, Steven R. Feldman, Diane J Martinez, Elizabeth Hoit Marchlewicz
Publikováno v:
The Journal of dermatological treatment. 32(2)
To compare treatment patterns and costs among psoriasis patients with and without metabolic conditions newly initiating a biologic or apremilast.Adult patients included had ≥1 prescription for secukinumab, adalimumab, ustekinumab, etanercept, or ap
Publikováno v:
Journal of Medical Economics. 19:403-413
Liraglutide has been shown to significantly improve glycemic control and reduce body weight while minimizing the risk of hypoglycemia in adult patients with type 2 diabetes (T2D). This study aimed to identify characteristics that predict clinical and